Obstetric anesthesia/analgesia does not affect disease course in multiple sclerosis: 10-year retrospective cohort study
نویسندگان
چکیده
منابع مشابه
Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
BACKGROUND There is increasing emphasis on using patient-reported outcomes (PROs) to complement traditional clinical outcomes in medical research, including in multiple sclerosis (MS). Research, particularly in oncology and heart failure, has shown that PROs can be prognostic of hard clinical endpoints such as survival time (time from study entry until death). However, unlike in oncology or car...
متن کاملClinical course of multiple sclerosis: A nationwide cohort study.
BACKGROUND The course of multiple sclerosis (MS) has been studied in several cohorts; however, results have varied significantly. OBJECTIVE To describe the clinical course of MS in a nationwide cohort of patients. METHOD Data from the Swedish MS register (SMSreg) were used to estimate the median time to the sustained Expanded Disability Status Scale (EDSS) scores 3.0, 4.0 and 6.0, onset of ...
متن کاملDisease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study
BACKGROUND The goal of this research was to compare the demographics, clinical characteristics and treatment patterns for newly diagnosed multiple sclerosis (MS) patients in a commercial managed care population who received disease-modifying drug (DMD) therapy versus those not receiving DMD therapy. METHODS A retrospective cohort study using US administrative healthcare claims identified indi...
متن کاملAdherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study
BACKGROUND Long-term therapies such as disease modifying therapy for Multiple Sclerosis (MS) demand high levels of medication adherence in order to reach acceptable outcomes. The objective of this study was to describe adherence to four disease modifying drugs (DMDs) among statutorily insured patients within two years following treatment initiation. These drugs were interferon beta-1a i.m. (Avo...
متن کاملCompliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
BACKGROUND Adherence to disease-modifying therapies (DMTs) results in the reduction of the number and severity of relapses and delays the progression of multiple sclerosis (MS). Patients with lower adherence rates experience more inpatient visits and higher MS-related medical costs. Fingolimod, the first oral DMT approved by the US Food and Drug Administration, may improve the access and compli...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Brain and Behavior
سال: 2018
ISSN: 2162-3279
DOI: 10.1002/brb3.1082